Regeneron (REGN) First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple Myeloma

Go back to Regeneron (REGN) First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple Myeloma
Regeneron (NASDAQ: REGN) Delayed: 612.50 +2.56 (0.42%)
Previous Close $609.94    52 Week High $592.36 
Open $604.46    52 Week Low $325.35 
Day High $613.56    P/E 160.76 
Day Low $594.90    EPS $3.81 
Volume 1,604,280